Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 13c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.74), $0.13 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $134 million versus the consensus estimate of $140.73 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Lowered to $92 at Oppenheimer
• Key things to know ahead of SK Hynix’s blockbuster US listing
• Northern Technologies (NTIC) Misses Q3 EPS by 12c